| Drug Name: | Diuron (330-54-1) |
|---|---|
| PubChem ID: | 3120 |
| SMILES: | CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl |
| InchiKey: | XMTQQYYKAHVGBJ-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 233.098 |
| LogP | : | 3.0869 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 32.34 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Hyperplasia | MetaADEDB |
| Necrosis | MetaADEDB |
| Urinary Bladder Diseases | MetaADEDB |
| Urinary Bladder Neoplasms | MetaADEDB |